Cas No.: | 1914993-95-5 |
Chemical Name: | Sodium (1R,2R,3S,5R)-2-[(6-deoxy-α-L-galactopyranosyl)oxy]-3-ethyl-5-[(38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl]cyclohexyl 2-acetamido-3-O-[(1S)-1-car boxylato-2-cyclohexylethyl]-2-deoxy-β-D-galactopyranoside |
Synonyms: | Uproleselan sodium;17ZJN0Q4CJ;Uproleselan sodium (USAN);Uproleselan sodium [USAN];D11310;4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxaoctatriacontanamide, N-(2-((((1R,3R,4R,5S)-3-((2-(acetylamino)-3-O-((1S)-1-carboxy-2-cyclohexylethyl)-2-deoxy-beta-D-galactopyranosyl)oxy)-4-((6-deoxy-alpha-L-galactopyranosyl)oxy)-5-ethylcyclohexyl)carbonyl)amino)ethyl)-, sodium salt (1:1);Sodium (2S)-2-(((2R,3R,4R,5R,6R)-3-acetamido-2-(((1R,2R,3S,;Sodium (1R,2R,3S,5R)-2-[(6-deoxy-α-L-galactopyranosyl)oxy]-3-ethyl-5-[(38-oxo-2,5,8,11,14,17,20,23,2 |
SMILES: | [Na+].O([C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O[C@H](C(=O)[O-])CC1CCCCC1)NC(C)=O)[C@@H]1C[C@H](C(NCCNC(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O)C[C@H](CC)[C@H]1O[C@H]1[C@H]([C@@H]([C@@H]([C@H](C)O1)O)O)O |
Formula: | C60H108N3NaO27 |
M.Wt: | 1326.49321269989 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A novel specific glycomimetic E-Selectin antagonist with Kd of 0.46 uM, IC50 of 1.75 uM; weakly inhibits L-selectin (IC50=2.9 uM) and >10 uM for P-selectin; not only mobilizes AML cells out of protective niches but also blocks NF-kB activation and prevents this E-selectin-mediated chemoresistance, thereby enhancing the therapeutic effects of standard chemotherapy; also overcomes MM metastasis and chemoresistance.Blood CancerPhase 2 Clinical |